Founded 2020
Founders Dr Peyman Salehian, Co-founder, Allozymes Dr Akbar Vahidi, Co-founder, Allozymes

Enzymes play a key role for hundreds of industrial purposes. The problem is that discovering the right enzyme with desired performance is like finding a needle in a haystack. Currently, there are two options: wait for evolution to take place or engineer it in the lab, costing millions of dollars and years of work with no guarantee of success. Allozymes unlocks enzyme potential using microfluidics, building the largest enzyme data set, and achieving 10X faster and cheaper development with 200X higher chance of success. Their ready to commercialize technology addresses a US$600B market with a pipeline of projects worth millions and products worth billions.

 


Founders

Dr Peyman
Salehian

Co-founder, Allozymes

Entrepreneur-scientist, managed international team as Head of Business Development

Dr Akbar
Vahidi

Co-founder, Allozymes

PhD in enzyme technology, delivered industrial projects to big pharma, food and biofuel companies

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.